{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:27:24Z","timestamp":1783445244678,"version":"3.54.6"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T00:00:00Z","timestamp":1706227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T00:00:00Z","timestamp":1706227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673434"],"award-info":[{"award-number":["81673434"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003968"],"award-info":[{"award-number":["82003968"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"\u201cDouble First-Class\u201d University project","award":["CPU2018GY22"],"award-info":[{"award-number":["CPU2018GY22"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00213-024-06530-y","type":"journal-article","created":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T05:02:01Z","timestamp":1706245321000},"page":"525-542","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The relevance between abnormally elevated serum ceramide and cognitive impairment in Alzheimer\u2019s disease model mice and its mechanism"],"prefix":"10.1007","volume":"241","author":[{"given":"Xin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzeng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,26]]},"reference":[{"key":"6530_CR1","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1097\/RLU.0000000000000666","volume":"40","author":"M Bailly","year":"2015","unstructured":"Bailly M, Ribeiro MJ, Vercouillie J, Hommet C, Gissot V, Camus V, Guilloteau D (2015) 18F-FDG and 18F-florbetapir PET in clinical practice: regional analysis in mild cognitive impairment and Alzheimer disease. Clin Nucl Med 40:e111\u2013e116","journal-title":"Clin Nucl Med"},{"key":"6530_CR2","doi-asserted-by":"crossref","first-page":"920958","DOI":"10.4061\/2011\/920958","volume":"2011","author":"L Barrier","year":"2010","unstructured":"Barrier L, Fauconneau B, No\u00ebl A, Ingrand S (2010) Ceramide and related-sphingolipid levels are not altered in disease-associated brain regions of APP and APP\/PS1 Mouse models of Alzheimer\u2019s disease: relationship with the lack of neurodegeneration? Int J Alzheimers Dis 2011:920958","journal-title":"Int J Alzheimers Dis"},{"key":"6530_CR3","doi-asserted-by":"crossref","unstructured":"Barth\u00e9lemy NR, Horie K, Sato C, Bateman RJ (2020) Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer\u2019s disease.\u00a0J Exp Med\u00a0217(11):e20200861","DOI":"10.1084\/jem.20200861"},{"key":"6530_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s12017-010-8114-x","volume":"12","author":"O Ben-David","year":"2010","unstructured":"Ben-David O, Futerman AH (2010) The role of the ceramide acyl chain length in neurodegeneration: involvement of ceramide synthases. NeuroMol Med 12:341\u2013350","journal-title":"NeuroMol Med"},{"key":"6530_CR5","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.2337\/diabetes.54.12.3458","volume":"54","author":"G Boden","year":"2005","unstructured":"Boden G, She P, Mozzoli M, Cheung P, Gumireddy K, Reddy P, Xiang X, Luo Z, Ruderman N (2005) Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. Diabetes 54:3458\u20133465","journal-title":"Diabetes"},{"key":"6530_CR6","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/alz.12301","volume":"17","author":"AM Brickman","year":"2021","unstructured":"Brickman AM, Manly JJ, Honig LS, Sanchez D, Reyes-Dumeyer D, Lantigua RA, Lao PJ, Stern Y, Vonsattel JP, Teich AF, Airey DC, Proctor NK, Dage JL, Mayeux R (2021) Plasma p-tau181, p-tau217, and other blood-based Alzheimer\u2019s disease biomarkers in a multi-ethnic, community study. Alzheimer Dement 17:1353\u20131364","journal-title":"Alzheimer Dement"},{"key":"6530_CR7","doi-asserted-by":"publisher","first-page":"e712","DOI":"10.1002\/ctm2.712","volume":"12","author":"M Cao","year":"2022","unstructured":"Cao M, Zhang S, Lam SM, Shui G (2022) Hepatic loss of CerS2 induces cell division defects via a mad2-mediated pathway. Clin Transl Med 12:e712","journal-title":"Clin Transl Med"},{"key":"6530_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.plipres.2014.01.004","volume":"54","author":"BM Castro","year":"2014","unstructured":"Castro BM, Prieto M, Silva LC (2014) Ceramide: a simple sphingolipid with unique biophysical properties. Prog Lipid Res 54:53\u201367","journal-title":"Prog Lipid Res"},{"key":"6530_CR9","doi-asserted-by":"crossref","unstructured":"Charytoniuk T, Sztolsztener K, Bielawiec P, Chabowski A, Konstantynowicz-Nowicka K, Harasim-Symbor E (2022) Cannabidiol downregulates myocardial de novo ceramide synthesis pathway in a rat model of high-fat diet-induced obesity. Int J Mol Sci 23(4):2232","DOI":"10.3390\/ijms23042232"},{"key":"6530_CR10","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3892\/ol.2017.6365","volume":"14","author":"J Chen","year":"2017","unstructured":"Chen J, Li X, Ma D, Liu T, Tian P, Wu C (2017) Ceramide synthase-4 orchestrates the cell proliferation and tumor growth of liver cancer in vitro and in vivo through the nuclear factor-\u03baB signaling pathway. Oncol Lett 14:1477\u20131483","journal-title":"Oncol Lett"},{"key":"6530_CR11","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/ptr.6846","volume":"35","author":"T Chen","year":"2021","unstructured":"Chen T, Liu S, Zheng M, Li Y, He L (2021) The effect of geniposide on chronic unpredictable mild stress-induced depressive mice through BTK\/TLR4\/NF-\u03baB and BDNF\/TrkB signaling pathways. Phytotherapy Research\u202f: PTR 35:932\u2013945","journal-title":"Phytotherapy Research : PTR"},{"key":"6530_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.brainresbull.2021.07.015","volume":"175","author":"ZY Cheng","year":"2021","unstructured":"Cheng ZY, Hu YH, Xia QP, Wang C, He L (2021) DRD1 agonist A-68930 improves mitochondrial dysfunction and cognitive deficits in a streptozotocin-induced mouse model. Brain Res Bull 175:136\u2013149","journal-title":"Brain Res Bull"},{"key":"6530_CR13","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.celrep.2014.08.057","volume":"9","author":"C Contreras","year":"2014","unstructured":"Contreras C, Gonz\u00e1lez-Garc\u00eda I, Mart\u00ednez-S\u00e1nchez N, Seoane-Collazo P, Jacas J, Morgan DA, Serra D, Gallego R, Gonzalez F, Casals N, Nogueiras R, Rahmouni K, Di\u00e9guez C, L\u00f3pez M (2014) Central ceramide-induced hypothalamic lipotoxicity and ER stress regulate energy balance. Cell Rep 9:366\u2013377","journal-title":"Cell Rep"},{"key":"6530_CR14","doi-asserted-by":"crossref","unstructured":"Custodia A, Aramburu-N\u00fa\u00f1ez M, Correa-Paz C, Posado-Fern\u00e1ndez A, G\u00f3mez-Larrauri A, Castillo J, G\u00f3mez-Mu\u00f1oz A, Sobrino T, Ouro A (2021) Ceramide metabolism and Parkinson\u2019s disease-therapeutic targets. Biomolecules 11(7):945","DOI":"10.3390\/biom11070945"},{"key":"6530_CR15","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1073\/pnas.0305799101","volume":"101","author":"RG Cutler","year":"2004","unstructured":"Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, Troncoso JC, Mattson MP (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 101:2070\u20132075","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6530_CR16","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1007\/s12035-018-1448-3","volume":"56","author":"K Czubowicz","year":"2019","unstructured":"Czubowicz K, J\u0119\u015bko H, Wencel P, Lukiw WJ, Strosznajder RP (2019) The role of ceramide and sphingosine-1-phosphate in Alzheimer\u2019s disease and other neurodegenerative disorders. Mol Neurobiol 56:5436\u20135455","journal-title":"Mol Neurobiol"},{"key":"6530_CR17","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3233\/JAD-2010-091726","volume":"21","author":"SM de la Monte","year":"2010","unstructured":"de la Monte SM, Tong M, Nguyen V, Setshedi M, Longato L, Wands JR (2010) Ceramide-mediated insulin resistance and impairment of cognitive-motor functions. J Alzheimer Dis\u202f: JAD 21:967\u2013984","journal-title":"J Alzheimer Dis : JAD"},{"key":"6530_CR18","doi-asserted-by":"publisher","first-page":"765252","DOI":"10.3389\/fnagi.2021.765252","volume":"13","author":"S den Hoedt","year":"2021","unstructured":"den Hoedt S, Crivelli SM, Leijten FPJ, Losen M, Stevens JAA, Man\u00e9-Damas M, de Vries HE, Walter J, Mirzaian M, Sijbrands EJG, Aerts J, Verhoeven AJM, Martinez-Martinez P, Mulder MT (2021) Effects of sex, age, and apolipoprotein E genotype on brain ceramides and sphingosine-1-phosphate in Alzheimer\u2019s disease and control mice. Front Aging Neurosci 13:765252","journal-title":"Front Aging Neurosci"},{"key":"6530_CR19","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.neurobiolaging.2014.02.012","volume":"35","author":"MB Dinkins","year":"2014","unstructured":"Dinkins MB, Dasgupta S, Wang G, Zhu G, Bieberich E (2014) Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer\u2019s disease. Neurobiol Aging 35:1792\u20131800","journal-title":"Neurobiol Aging"},{"key":"6530_CR20","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.2174\/1567205016666190827112546","volume":"16","author":"B Du","year":"2019","unstructured":"Du B, Lian Y, Chen C, Zhang H, Bi Y, Fan C, Bi X (2019) Strong association of serum GSK-3\u03b2\/BDNF ratio with mild cognitive impairment in elderly type 2 diabetic patients. Curr Alzheimer Res 16:1151\u20131160","journal-title":"Curr Alzheimer Res"},{"key":"6530_CR21","doi-asserted-by":"publisher","first-page":"108672","DOI":"10.1016\/j.abb.2020.108672","volume":"697","author":"HB Ferreira","year":"2021","unstructured":"Ferreira HB, Melo T, Monteiro A, Paiva A, Domingues P, Domingues MR (2021) Serum phospholipidomics reveals altered lipid profile and promising biomarkers in multiple sclerosis. Arch Biochem Biophys 697:108672","journal-title":"Arch Biochem Biophys"},{"key":"6530_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/syn.21642","volume":"67","author":"JC Gandy","year":"2013","unstructured":"Gandy JC, Melendez-Ferro M, Bijur GN, Van Leuven F, Roche JK, Lechat B, Devijver H, Demedts D, Perez-Costas E, Roberts RC (2013) Glycogen synthase kinase-3\u03b2 (GSK3\u03b2) expression in a mouse model of Alzheimer\u2019s disease: a light and electron microscopy study. Synapse (new York, NY) 67:313\u2013327","journal-title":"Synapse (new York, NY)"},{"key":"6530_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jneumeth.2009.05.009","volume":"181","author":"V Gautheron","year":"2009","unstructured":"Gautheron V, Auffret A, Mattson MP, Mariani J, Vernet-der Garabedian B (2009) A new and simple approach for genotyping Alzheimer\u2019s disease presenilin-1 mutant knock-in mice. J Neurosci Methods 181:235\u2013240","journal-title":"J Neurosci Methods"},{"key":"6530_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S1474-4422(20)30440-3","volume":"20","author":"J Graff-Radford","year":"2021","unstructured":"Graff-Radford J, Yong KXX, Apostolova LG, Bouwman FH, Carrillo M, Dickerson BC, Rabinovici GD, Schott JM, Jones DT, Murray ME (2021) New insights into atypical Alzheimer\u2019s disease in the era of biomarkers. Lancet Neurol 20:222\u2013234","journal-title":"Lancet Neurol"},{"key":"6530_CR25","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/j.1365-2826.2007.01607.x","volume":"19","author":"A Gyte","year":"2007","unstructured":"Gyte A, Pritchard LE, Jones HB, Brennand JC, White A (2007) Reduced expression of the KATP channel subunit, Kir6.2, is associated with decreased expression of neuropeptide Y and agouti-related protein in the hypothalami of Zucker diabetic fatty rats. J Neuroendocrinol 19:941\u2013951","journal-title":"J Neuroendocrinol"},{"key":"6530_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neurobiolaging.2018.02.028","volume":"67","author":"PJ Hallett","year":"2018","unstructured":"Hallett PJ, Huebecker M, Brekk OR, Moloney EB, Rocha EM, Priestman DA, Platt FM, Isacson O (2018) Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of the mouse brain. Neurobiol Aging 67:189\u2013200","journal-title":"Neurobiol Aging"},{"key":"6530_CR27","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.cell.2019.05.008","volume":"177","author":"P Hammerschmidt","year":"2019","unstructured":"Hammerschmidt P, Ostkotte D, Nolte H, Gerl MJ, Jais A, Brunner HL, Sprenger HG, Awazawa M, Nicholls HT, Turpin-Nolan SM, Langer T, Kr\u00fcger M, Br\u00fcgger B, Br\u00fcning JC (2019) CerS6-derived sphingolipids interact with Mff and promote mitochondrial fragmentation in obesity. Cell 177:1536-1552.e23","journal-title":"Cell"},{"key":"6530_CR28","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1172\/JCI43378","volume":"121","author":"WL Holland","year":"2011","unstructured":"Holland WL, Bikman BT, Wang LP, Yuguang G, Sargent KM, Bulchand S, Knotts TA, Shui G, Clegg DJ, Wenk MR, Pagliassotti MJ, Scherer PE, Summers SA (2011) Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J Clin Invest 121:1858\u20131870","journal-title":"J Clin Invest"},{"key":"6530_CR29","first-page":"110","volume":"518","author":"L Hong","year":"2021","unstructured":"Hong L, Hongmei W, Leijie X, Dandan Z, Peng L, Zhifei H, Ruimin M, Yijun S, Guanghui Z, Guojun Z (2021) Serum ceramide concentrations are associated with depression in patients after ischemic stroke-a two-center case-controlled study. Clinica chimica acta. Int J Clin Chem 518:110\u2013115","journal-title":"Int J Clin Chem"},{"key":"6530_CR30","doi-asserted-by":"crossref","unstructured":"Jiang M, Huang S, Duan W, Liu Q, Lei M (2019) Inhibition of acid sphingomyelinase activity ameliorates endothelial dysfunction in db\/db mice.\u00a0Biosci Rep\u00a039(4):BSR20182144","DOI":"10.1042\/BSR20182144"},{"key":"6530_CR31","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s11064-007-9297-x","volume":"32","author":"P Katsel","year":"2007","unstructured":"Katsel P, Li C, Haroutunian V (2007) Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer\u2019s disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer\u2019s disease? Neurochem Res 32:845\u2013856","journal-title":"Neurochem Res"},{"key":"6530_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0006-8993(00)02060-6","volume":"862","author":"EM Kim","year":"2000","unstructured":"Kim EM, O\u2019Hare E, Grace MK, Welch CC, Billington CJ, Levine AS (2000) ARC POMC mRNA and PVN alpha-MSH are lower in obese relative to lean Zucker rats. Brain Res 862:11\u201316","journal-title":"Brain Res"},{"key":"6530_CR33","doi-asserted-by":"crossref","unstructured":"Lane CA, Hardy J, Schott JM (2018) Alzheimer disease. Eur J Neurol\u00a025(1):59\u201370","DOI":"10.1111\/ene.13439"},{"key":"6530_CR34","doi-asserted-by":"publisher","first-page":"5677","DOI":"10.1074\/jbc.M707386200","volume":"283","author":"EL Laviad","year":"2008","unstructured":"Laviad EL, Albee L, Pankova-Kholmyansky I, Epstein S, Park H, Merrill AH Jr, Futerman AH (2008) Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate. J Biol Chem 283:5677\u20135684","journal-title":"J Biol Chem"},{"key":"6530_CR35","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.lfs.2011.01.026","volume":"88","author":"A Leckstrom","year":"2011","unstructured":"Leckstrom A, Lew PS, Poritsanos NJ, Mizuno TM (2011) Central melanocortin receptor agonist reduces hepatic lipogenic gene expression in streptozotocin-induced diabetic mice. Life Sci 88:664\u2013669","journal-title":"Life Sci"},{"key":"6530_CR36","doi-asserted-by":"publisher","first-page":"175443","DOI":"10.1016\/j.ejphar.2022.175443","volume":"938","author":"X Liu","year":"2023","unstructured":"Liu X, Cheng ZY, Li YF, Liu C, Wang C, Gong XJ, He L (2023) Dopamine D2 receptor agonist bromocriptine ameliorates A\u03b2(1\u201342)-induced memory deficits and neuroinflammation in mice. Eur J Pharmacol 938:175443","journal-title":"Eur J Pharmacol"},{"key":"6530_CR37","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/acn3.50973","volume":"7","author":"ER McGrath","year":"2020","unstructured":"McGrath ER, Himali JJ, Xanthakis V, Duncan MS, Schaffer JE, Ory DS, Peterson LR, DeCarli C, Pase MP, Satizabal CL, Vasan RS, Beiser AS, Seshadri S (2020) Circulating ceramide ratios and risk of vascular brain aging and dementia. Ann Clin Transl Neurol 7:160\u2013168","journal-title":"Ann Clin Transl Neurol"},{"key":"6530_CR38","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1212\/WNL.0b013e318264e380","volume":"79","author":"MM Mielke","year":"2012","unstructured":"Mielke MM, Bandaru VV, Haughey NJ, Xia J, Fried LP, Yasar S, Albert M, Varma V, Harris G, Schneider EB, Rabins PV, Bandeen-Roche K, Lyketsos CG, Carlson MC (2012) Serum ceramides increase the risk of Alzheimer disease: the Women\u2019s Health and Aging Study II. Neurology 79:633\u2013641","journal-title":"Neurology"},{"key":"6530_CR39","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist S, Janelidze S, Quiroz YT, Zetterberg H, Lopera F, Stomrud E, Su Y, Chen Y, Serrano GE, Leuzy A, Mattsson-Carlgren N, Strandberg O, Smith R, Villegas A, Sepulveda-Falla D, Chai X, Proctor NK, Beach TG, Blennow K, Dage JL, Reiman EM, Hansson O (2020) Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA 324:772\u2013781","journal-title":"JAMA"},{"key":"6530_CR40","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/brain\/awy347","volume":"142","author":"JC Park","year":"2019","unstructured":"Park JC, Han SH, Yi D, Byun MS, Lee JH, Jang S, Ko K, Jeon SY, Lee YS, Kim YK, Lee DY, Mook-Jung I (2019) Plasma tau\/amyloid-\u03b21-42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer\u2019s disease. Brain 142:771\u2013786","journal-title":"Brain"},{"key":"6530_CR41","first-page":"419","volume":"43","author":"WJ Park","year":"2020","unstructured":"Park WJ, Song JH, Kim GT, Park TS (2020) Ceramide and sphingosine 1-phosphate in liver diseases. Mol Cells 43:419\u2013430","journal-title":"Mol Cells"},{"key":"6530_CR42","doi-asserted-by":"crossref","unstructured":"Porter WD, Flatt PR, H\u00f6lscher C, Gault VA (2013) Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob\/ob mice. Int J Obes 37:678\u2013684","DOI":"10.1038\/ijo.2012.91"},{"key":"6530_CR43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.molmet.2018.12.008","volume":"21","author":"S Raichur","year":"2019","unstructured":"Raichur S, Brunner B, Bielohuby M, Hansen G, Pfenninger A, Wang B, Bruning JC, Larsen PJ, Tennagels N (2019) The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach. Mol Metab 21:36\u201350","journal-title":"Mol Metab"},{"key":"6530_CR44","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1007\/s12035-019-01858-5","volume":"57","author":"JC Shieh","year":"2020","unstructured":"Shieh JC, Huang PT, Lin YF (2020) Alzheimer\u2019s disease and diabetes: insulin signaling as the bridge linking two pathologies. Mol Neurobiol 57:1966\u20131977","journal-title":"Mol Neurobiol"},{"key":"6530_CR45","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/brain\/awab294","volume":"145","author":"A Strom","year":"2022","unstructured":"Strom A, Iaccarino L, Edwards L, Lesman-Segev OH, Soleimani-Meigooni DN, Pham J, Baker SL, Landau SM, Jagust WJ, Miller BL, Rosen HJ, Gorno-Tempini ML, Rabinovici GD, La Joie R (2022) Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer\u2019s disease. Brain 145:713\u2013728","journal-title":"Brain"},{"key":"6530_CR46","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/0024-3205(94)00393-9","volume":"55","author":"L Svennerholm","year":"1994","unstructured":"Svennerholm L (1994) Gangliosides\u2013a new therapeutic agent against stroke and Alzheimer\u2019s disease. Life Sci 55:2125\u20132134","journal-title":"Life Sci"},{"key":"6530_CR47","doi-asserted-by":"crossref","unstructured":"Thota RN, Rosato JI, Dias CB, Burrows TL, Martins RN, Garg ML (2020) Dietary supplementation with curcumin reduce circulating levels of glycogen synthase kinase-3\u03b2 and islet amyloid polypeptide in adults with high risk of type 2 diabetes and Alzheimer\u2019s disease. Nutrients 12(4):1032","DOI":"10.3390\/nu12041032"},{"key":"6530_CR48","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/glia.20626","volume":"56","author":"G Wang","year":"2008","unstructured":"Wang G, Silva J, Dasgupta S, Bieberich E (2008) Long-chain ceramide is elevated in presenilin 1 (PS1M146V) mouse brain and induces apoptosis in PS1 astrocytes. Glia 56:449\u2013456","journal-title":"Glia"},{"key":"6530_CR49","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1007\/s00125-012-2649-3","volume":"55","author":"MJ Watt","year":"2012","unstructured":"Watt MJ, Barnett AC, Bruce CR, Schenk S, Horowitz JF, Hoy AJ (2012) Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide. Diabetologia 55:2741\u20132746","journal-title":"Diabetologia"},{"key":"6530_CR50","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jalz.2017.08.012","volume":"14","author":"M Xu","year":"2018","unstructured":"Xu M, Zhang DF, Luo R, Wu Y, Zhou H, Kong LL, Bi R, Yao YG (2018) A systematic integrated analysis of brain expression profiles reveals YAP1 and other prioritized hub genes as important upstream regulators in Alzheimer\u2019s disease. Alzheimer Dement 14:215\u2013229","journal-title":"Alzheimer Dement"},{"key":"6530_CR51","doi-asserted-by":"publisher","first-page":"4754195","DOI":"10.1155\/2020\/4754195","volume":"2020","author":"W Yang","year":"2020","unstructured":"Yang W, Liu Y, Xu QQ, Xian YF, Lin ZX (2020) Sulforaphene ameliorates neuroinflammation and hyperphosphorylated tau protein via regulating the PI3K\/Akt\/GSK-3\u03b2 pathway in experimental models of Alzheimer\u2019s disease. Oxid Med Cell Longev 2020:4754195","journal-title":"Oxid Med Cell Longev"},{"key":"6530_CR52","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-3-030-21162-2_4","volume":"1159","author":"ID Zelnik","year":"2019","unstructured":"Zelnik ID, Rozman B, Rosenfeld-Gur E, Ben-Dor S, Futerman AH (2019) A stroll down the CerS lane. Adv Exp Med Biol 1159:49\u201363","journal-title":"Adv Exp Med Biol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-024-06530-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-024-06530-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-024-06530-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T06:17:41Z","timestamp":1731133061000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-024-06530-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,26]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["6530"],"URL":"https:\/\/doi.org\/10.1007\/s00213-024-06530-y","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,26]]},"assertion":[{"value":"26 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}